markkerit

name

• markkerit

Works about markkerit

• [¹⁸F]fluoroerythronitroimidazole, tumor hypoxia and positron emission tomography
• Adulthood atopic dermatitis : focus on the skin barrier, epidemiology, and the long-term outcome
• Alzheimer's disease cerebrospinal fluid biomarkers in a cognitively healthy population and in patients with memory disorders :
• Amniotic fluid biomarkers in the diagnosis of intra-amniotic infection in preterm singleton pregnancies : association with microbial invasion of the amniotic cavity and histologic chorioamnionitis
• Angiogenesis in pediatric malignancies from molecular markers to therapeutic applications
• Application of next generation sequencing in the diagnosis of mutations in exhaled breath condensate of lung cancer and mesothelioma patients : final project report for the Finnish Work Environment Fund = Mutaatioanalyysin suorittaminen asbestialtistuneiden mesoteliooma- ja keuhkosyöpäpotilaiden uloshengitystiivisteestä : loppuraportti Työsuojelurahastolle
• Association and interplay of genetic and epigenetic variants in smoking behavior
• Biodistribution studies in small animal models using pre-clinical SPECT/CT imaging
• Biological prognostic and predictive markers in Hodgkin lymphoma
• Biomarkers for assessing ethanol consumption and the development of alcoholic liver disease :
• Biomarkers for non-alcoholic steatohepatitis with special emphasis on lipid metabolism
• Biomarkers for predicting the outcome of Puumala hantavirus infection
• Biomarkers in acute respiratory failure
• Biomarkers in multiple sclerosis :
• Biomarkers of chronic allograft injury in children after renal transplantation
• Biomarkers of ethanol consumption : studies on carbohydrate-deficient transferrin, sialic acid and traditional markers
• Biomarkers, medical treatment and fetal intrapartum surveillance in intrahepatic cholestasis of pregnancy
• Blood and cerebrospinal fluid biomarkers of Alzheimer's disease : application in the evaluation of progression and differential diagnosis
• Body composition and molecular reflections of obesity-related cardio-metabolic disorders : a cross-sectional and longitudinal study in women
• Canine idiopathic pulmonary fibrosis : clinical disease, biomarkers and histopathological features
• Cardiac troponin specific autoantibodies :
• Cardiovascular biomarkers in dementia risk prediction
• Cardiovascular events in hip fracture patients
• Cell-free DNA as a novel biomarker of aging : characterization and genetic regulation
• Cerebrospinal fluid and plasma biomarkers in the differential diagnosis of neurodegenerative diseases
• Characterization of diagnostic biomarkers for Mycobacterium tuberculosis infection
• Chronic obstructive pulmonary disease (COPD) : from biomarkers to clinical phenotypes
• Circulating fatty acids : associations with diet, genetic variations, low-grade inflammation and type 2 diabetes
• Clinical and genetic markers in disease progression : a study among subjects with obstructive lung diseases
• Combining oncolytic immunotherapy with conventional cancer treatments
• Comparison between septic and non-septic patients
• Complement factor H in kidney and urinary tract diseases
• Complement system in cutaneous squamous cell carcinoma
• Computational analysis of microRNAs in biomedicine
• Computational methods to analyze molecular determinants behind phenotypes
• Consequences of balanced translocations and loss-of-function mutations
• Conventional and novel cardiovascular risk factors in young Finns and their associations with structural and functional vascular changes of subclinical atherosclerosis : the cardiovascular risk in young Finns study
• Determinants and predictive value of markers of glycemia and dyslipidemia for type 2 diabetes and cardiovascular disease
• Development of liquid chromatography mass spectrometric methods for quantification of metabolites from cellular level to clinical biomarkers
• Development of novel probes for enterovirus B group to study uncoating and infection
• Emerging novel prognostic markers in pancreatic ductal adenocarcinoma
• Expression of hyaluronan synthases and hyaluronidases in gynecological malignancies
• Finnish population genetics in a forensic context
• Forms of human chorionic gonadotropin in serum of testicular cancer patients
• Functional magnetic resonance imaging in Alzheimer's disease
• Gamma-glutamyl transferase as a marker of alcohol abuse : effects of moderate drinking, obesity and increasing age on reference intervals
• Gelatinases, their tissue inhibitors and p53 in lymphomas
• Gene polymorphisms affecting the production of C-reactive protein : clinical implications
• Glycan binding proteins in therapeutic mesenchymal stem cell research
• Identification and characterization of genes and proteins involved in the development and progression of melanomas
• Identification of 1p21-22 amplification in bladder cancer and expression of non-coding RNAs in prostate cancer
• Identification of a novel glioma homing peptide and functional characterization of its interacting partner, MDGI
• Identification of biomarkers for type 2 diabetes
• Identification of novel genes involved in the pathophysiology of adrenocortical tumorigenesis
• Inflammation and early atherosclerosis
• Inflammatory biomarkers in multiple sclerosis
• Magnetic resonance imaging of progressive changes in traumatic brain injury and epileptogenesis
• Markers of systemic inflammation in diagnostics and in prediction of outcome of community-acquired infection
• Mass spectrometry in clinical protein biomarker discovery
• Matrix metalloproteinases and toll-like receptors in early-stage oral tongue squamous cell carcinoma
• Mechanisms of cell invasion and fibrovascular complications in cancer and diabetic retinopathy
• MicroRNAs as predictive and prognostic biomarkers in human neoplasia : with specific focus on colorectal cancer, giant cell tumor of bone, and leukemias
• Migration and adhesion associated molecules in lymphoma biology and their potential roles as biomarkers
• Molecular biomarkers and histopathological parameters in prostate cancer diagnostics and prognostics
• Molecular classification of colorectal cancer
• Molecular markers in Finnish lung cancers
• Molecular pathogenesis of large granular lymphocytic leukemia
• Neutrophil gelatinase-associated lipocalin in kidney and liver transplantation
• New biomarkers in glioma : PET/CT imaging and the prognostic value of somatostatin receptor subtype 2
• NIR-Vis up-conversion luminescence in the Yb³⁺, Er³⁺ doped Y₂O₂S, ZrO₂, and NaYF₄ nanomaterials
• Noninvasive biomarkers for early smoking related lung disease
• Novel imaging methods and biomarkers in the screening of late cardiac effects after childhood cancer
• Novel immunological markers of Lyme borreliosis
• Novel prognostic biomarkers for renal cell carcinoma
• Novel use of biomarkers and their combinations for detecting excessive drinking
• Oropharyngeal cancer : changing management and the role of Toll-like receptors
• Ovarian cancer marker HE4 in hormone-related gynecological conditions and diagnosis of ovarian granulosa cell tumors
• Peripheral blood biomarkers in aneurysmal subarachnoid hemorrhage
• Polygenic risk scores, transcriptomics, and molecular mechanisms of Alzheimer's disease-related risk genes
• Potential urinary biomarkers of acute kidney injury in domestic animals
• Predictive biomarkers in diffuse gliomas and non-small cell lung cancer
• Preoperative assessment of endometrial carcinoma
• Prognostic biomarkers in colorectal cancer
• Prognostic biomarkers in endometrioid endometrial carcinoma
• Prognostic biomarkers in pancreatic ductal adenocarcinoma
• Prognostic models in traumatic brain injury
• PV-1 : leukocyte trafficking molecule and vascular marker
• Regulation of murine hepatic Cytochrome P450 2a5 expression by transcription factor Nuclear factor (erythroid-derived 2)-like 2
• Roles of novel biomarkers in progression of cutacenous squamous cell carcinoma
• Signalling and expression of the Ang-Tie pathway in tumor vasculature
• Skeletal and extra-skeletal characteristics of WNT1 osteoporosis
• Soluble urokinase Plasminogen Activator Receptor in critical illness
• Species-specific effects of dioxin exposure on xenobiotic metabolism and hard tissue in voles
• Systemic inflammation in colorectal cancer :
• Systems and mechanistic understanding of genetic predisposition to prostate cancer
• The allergy and asthma protective effects of farm environment and pet animals :
• The effect of cardiovascular stress on cognition and mortality :
• The human microbiome in Parkinson’s disease and primary sclerosing cholangitis
• The prognostic and predictive value of selected biomarkers in colorectal cancer
• The proteasome-associated Deubiquitinase UCHL5/UBH-4 in proteasome modulation and as a prognostic marker in gastrointestinal cancers
• The role of electrocardiographic abnormalities, obesity, and diabetes in risk stratification for sudden cardiac death in the general population
• Tissue proteomes : quantitative mass spectrometry of murine liver and ovarian endometrioma
• Toll-like receptor 9 in breast cancer
• Transforming growth factor β1 genotype, p16 expression, and treatment outcome in head and neck squamous cell carcinoma
• Translational perspectives on matrix metalloproteinase 8 and other inflammatory biomarkers in cardiovascular diseases
• Tumor dormancy in breast cancer
• Tumor suppressor functions of epithelial integrity genes in breast cancer
• Tumour glycosylation and glycoproteins as biomarkers in colorectal cancer
• TWIST and oxidative stress related biomarkers in outcome prediction of prostate cancer patients treated with radical prostatectomy
• Usefulness of cerebrospinal fluid biomarkers in diagnosis of early Alzheimerʼs disease
• Valimotyöntekijöiden seurantatutkimus :
• Various mass spectrometric methods for the screening and identification of metabolites of toxic and incapacitating chemicals